NCT03049657View on ClinicalTrials.gov

Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention

NACompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

February 2, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

January 28, 2019

Conditions
Coronary Artery DiseaseDrug-eluting Stent
Interventions
DEVICE

Angiolite

Percutaneous coronary intervention

DEVICE

Xience

Percutaneous coronary intervention

Trial Locations (11)

15706

Hospital Universitario de Santiago de Compostela, Santiago de Compostela

18014

Hospital Virgen de las Nieves, Granada

21005

Hospital Juan Ramón Jiménez, Huelva

24001

Hospital de León, León

28046

Hospital La Paz, Madrid

30120

Hospital Virgen de la Arrixaca, El Palmar

39008

Hospital Marqués de Valdecilla, Santander

45005

Hospital Virgen de la Salud, Toledo

47003

Hospital Clinico Universitario de Valladolid, Valladolid

06006

Hospital Infanta Cristina, Badajoz

08035

Hospital Valle de Hebrón, Barcelona

All Listed Sponsors
lead

Cardiva2 S.L.

INDUSTRY

NCT03049657 - Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter